Takimoto Chris H
Insider CIK 1743780 · IGMS Chief Medical Officer · FTSV Chief Medical Officer · ALXO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2024-09-13 | 2024-09-17 | 1,487 | $11.54 | $17.2K | 154,331 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer deriv | 2024-07-19 | 2024-07-23 | 150,000 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-07-19 | 2024-07-23 | 43,750 | — | $0 | 139,568 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-07-19 | 2024-07-23 | 16,250 | — | $0 | 155,818 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2024-06-14 | 2024-06-18 | 1,570 | $7.58 | $11.9K | 95,818 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-05-15 | 2024-06-18 | 3,000 | $5.02 | $15.1K | 97,388 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 2,535 | $10.17 | $25.8K | 94,388 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 2,889 | $9.88 | $28.5K | 96,923 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 92,500 | — | $0 | 92,500 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-03-12 | 2024-03-14 | 46,250 | — | $0 | 99,812 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2023-11-29 | 2023-12-01 | 1,180 | $6.21 | $7.3K | 53,562 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2023-05-23 | 2023-05-25 | 15 | $13.01 | $195 | 54,742 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2023-05-23 | 2023-05-25 | 1,244 | $12.30 | $15.3K | 54,757 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-05-15 | 2023-05-25 | 962 | $11.71 | $11.3K | 56,001 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 52,500 | — | $0 | 52,500 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-04-04 | 2023-04-06 | 26,250 | — | $0 | 55,039 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2023-03-14 | 2023-03-16 | 1,768 | $18.73 | $33.1K | 28,789 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-20 | 3,492 | $18.77 | $65.5K | 32,495 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-20 | 1,938 | $19.36 | $37.5K | 30,557 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2022-11-23 | 2022-11-28 | 600 | $21.38 | $12.8K | 36,264 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2022-11-23 | 2022-11-28 | 277 | $21.99 | $6.1K | 35,987 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2022-05-24 | 2022-05-26 | 938 | $17.10 | $16.0K | 36,864 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-05-13 | 2022-05-17 | 825 | $12.38 | $10.2K | 37,802 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-03-15 | 2022-03-17 | 14,477 | — | $0 | 36,977 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2022-03-12 | 2022-03-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-03-12 | 2022-03-15 | 12,500 | — | $0 | 22,500 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2021-11-15 | 2021-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2021-07-30 | 2021-08-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 58,114 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 4,570 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 70,398 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 113,153 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 44,710 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer | 2020-04-07 | 2020-04-07 | 3,906 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 7,020 | — | $0 | 70,398 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 49,627 | — | $0 | 58,114 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 8,333 | — | $0 | 4,570 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 11,418 | — | $0 | 44,710 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 2,797 | — | $0 | 113,153 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 79,195 | $95.42 | $7.56M | 3,906 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 49,627 | $2.02 | $100.2K | 53,533 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 8,333 | $4.88 | $40.7K | 61,866 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 7,020 | $5.27 | $37.0K | 68,886 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 11,418 | $8.76 | $100.0K | 80,304 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 2,797 | $35.75 | $100.0K | 83,101 | SEC↗ |
| FTSV Forty Seven, Inc. | A Award deriv | 2019-12-13 | 2019-12-17 | 115,950 | — | $0 | 115,950 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-12-10 | 2019-12-11 | 10,000 | $35.00 | $350.0K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-12-10 | 2019-12-11 | 10,000 | $2.02 | $20.2K | 10,000 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-12-09 | 2019-12-10 | 10,000 | — | $0 | 117,741 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 10,000 | — | $0 | 107,741 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-12-09 | 2019-12-10 | 10,000 | $30.00 | $300.0K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-12-09 | 2019-12-10 | 10,000 | $2.02 | $20.2K | 10,000 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-08-16 | 2019-08-21 | 663 | $6.36 | $4.2K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-05-03 | 2019-05-07 | 8,000 | — | $0 | 127,741 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-05-03 | 2019-05-07 | 8,000 | $17.99 | $143.9K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-05-03 | 2019-05-07 | 8,000 | $2.02 | $16.2K | 8,000 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-04-04 | 2019-04-08 | 8,000 | $2.02 | $16.2K | 8,000 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-04-04 | 2019-04-08 | 8,000 | $16.39 | $131.1K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-03-04 | 2019-04-08 | 8,000 | — | $0 | 135,741 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-03-04 | 2019-03-06 | 8,000 | — | $0 | 143,741 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-03-04 | 2019-03-06 | 8,000 | $16.94 | $135.5K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-03-04 | 2019-03-06 | 8,000 | $2.02 | $16.2K | 8,000 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-02-19 | 2019-02-21 | 2,500 | $15.05 | $37.6K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-02-04 | 2019-02-05 | 8,000 | — | $0 | 151,741 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-02-04 | 2019-02-05 | 8,000 | $2.02 | $16.2K | 8,000 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-02-04 | 2019-02-05 | 8,000 | $14.86 | $118.9K | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-01-04 | 2019-01-08 | 8,000 | — | $0 | 159,741 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-01-04 | 2019-01-08 | 8,000 | $2.02 | $16.2K | 8,000 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-01-04 | 2019-01-08 | 8,000 | $15.55 | $124.4K | 0 | SEC↗ |